EQUITY (Tables)
|
3 Months Ended |
Mar. 31, 2025 |
|---|
| Equity [Abstract] |
|
| Schedule of Warrants Outstanding and Exercisable |
The following table summarizes the status of warrants and related transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Derivative (Equity) Warrants |
|
Derivative Liabilities Warrants |
|
Total Number of Warrants |
|
Weighted - Average Exercise Price |
Balance as of January 1, 2025 |
50,518,536 |
|
21,400,000 |
|
71,918,536 |
|
$ |
1.03 |
|
Granted (1)
|
8,010,626 |
|
|
— |
|
|
8,010,626 |
|
|
$ |
0.48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of March 31, 2025 |
58,529,162 |
|
21,400,000 |
|
79,929,162 |
|
$ |
0.98 |
|
Exercisable as of March 31, 2025 |
56,959,162 |
|
21,400,000 |
|
78,359,162 |
|
$ |
0.98 |
|
|
| Schedule of Share-Based Payment Award, Warrants, Valuation Assumptions |
The following assumptions were used for the calculation at date of issuance:
|
|
|
|
|
|
| Weighted average stock price |
$0.33 |
| Weighted average expected stock price volatility |
91.8% |
| Expected annual dividend yield |
0% |
Weighted average expected life of warrants |
5.0 years |
| Weighted average risk-free annual interest rate |
4.1% |
| Weighted average grant date fair value |
$0.22 |
|
| Schedule of Stock Options Outstanding |
The following table summarizes the status of stock options and related transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Stock Options |
|
Weighted-Average Per Share Exercise Price |
| Issued and Outstanding as of January 1, 2025 |
26,769,419 |
|
|
$ |
0.79 |
|
| Granted |
670,000 |
|
|
$ |
0.30 |
|
|
|
|
|
| Cancelled/forfeited/expired |
(2,728,667) |
|
|
$ |
0.76 |
|
| Issued and Outstanding as of March 31, 2025 |
24,710,752 |
|
|
$ |
0.78 |
|
| Exercisable as of March 31, 2025 |
14,060,630 |
|
|
$ |
0.96 |
|
|
| Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions |
The following assumptions were used for the calculation at date of grant:
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
2025 |
|
2024 |
| Weighted average stock price |
$0.29 |
|
$0.70 |
| Weighted average expected stock price volatility |
92.0% |
|
77.1% |
| Expected annual dividend yield |
0% |
|
0% |
| Weighted average expected life |
5.0 years |
|
5.1 years |
| Weighted average risk-free annual interest rate |
4.0% |
|
4.3% |
| Weighted average grant date fair value |
$0.21 |
|
$0.46 |
|
| Schedule of Components of Share-based Compensation Expense |
The components of share-based compensation expense are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
|
|
2025 |
|
2024 |
Stock options expense (forfeiture) |
|
|
|
|
$ |
(381) |
|
|
$ |
1,355 |
|
| Restricted stock |
|
|
|
|
— |
|
|
1 |
|
| Warrants |
|
|
|
|
74 |
|
|
168 |
|
Total share-based compensation expense (forfeiture) |
|
|
|
|
$ |
(307) |
|
|
$ |
1,524 |
|
|